Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.48 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.45 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | SETDB1 | Q15047 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13167369 | 0.83 | LIPG (0.49) | HPGDHTTPOLBMTNR1AMTNR1B | |
| SCHEMBL885000 | 0.79 | MTNR1A (0.71) | HPGDHTTMTNR1AMTNR1BTSHR | |
| SCHEMBL26698320 | 0.77 | ALDH1A1 (0.51) | HPGDHTTPOLBMTNR1AMTNR1B | |
| SCHEMBL5724959 | 0.76 | LMNA (0.59) | HPGDHTTPOLBALDH1A1KMT2A | |
| SCHEMBL14204990 | 0.76 | SETDB1 (0.59) | HPGDMTNR1AMTNR1BALDH1A1KMT2A | |
| SCHEMBL947356 | 0.75 | TAS1R3 (0.56) | HPGDHTTPOLBTSHRALDH1A1 | |
| SCHEMBL29676259 | 0.74 | MTNR1A (0.51) | HPGDHTTPOLBMTNR1AMTNR1B | |
| SCHEMBL17468449 | 0.74 | PPARG (0.54) | HPGDMTNR1AMTNR1BHDAC1 | |
| SCHEMBL16437111 | 0.73 | TSHR (0.53) | HPGDMTNR1AMTNR1BTSHRALDH1A1 | |
| SCHEMBL15434628 | 0.72 | MTNR1A (0.49) | HPGDHTTMTNR1AMTNR1BNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1527042-B1 | METHOD FOR PRODUCING AMINOALKOXY BENZYLAMINES AND AMINOALKOXY BENZONITRILES AS INTERMEDIATES | BASF SE (DE) | 2008-07-23 | — | — | EP | disclosed |
| US-7256312-B2 | Method for producing aminoalkoxy benzylamines and aminoalkoxy benzonitriles as intermediates | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-14 | — | — | US | disclosed |
| US-20050256340-A1 | Method for producing aminoalkoxy benzylamines and aminoalkoxy benzonitriles as intermediates | BASF AKTIENGESELLSCHAFT (DE) | 2005-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256340-A1 | Method for producing aminoalkoxy benzylamines and aminoalkoxy benzonitriles as intermediates | BCAT1, BCAT2, ALKBH3 | HPGD 897/4885HTT 1410/4885POLB 703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.